P000057/S013: Ascension MCP
FDA’s recorded scope: Approval for a change to the raw material used in the processing of the subject device
Explore this company’s associated devices, FDA decisions and regulatory history.

MedtechLedger currently links 7 FDA records to the applicant name Smith & Nephew, Inc.. The collection includes 5 510(k) clearances. 1 entry is a PMA supplement. 1 entry is a 30-day notice. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Aug 5, 2025 to Oct 27, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code MBI appears in 2 of the 7 linked filings. The collection spans 5 FDA product codes and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
The largest PMA family in this collection is P000057, with 2 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes. 2 linked filings have a current plain-language explanation checked against the recorded FDA decision.
Applicant mailing address recorded by FDA: 150 Minuteman Rd., Andover, MA, 01810, US. Recorded on K263461, decision dated Oct 27, 2026.
Staple, Implantable; Fastener, Fixation, Nondegradable, Soft Tissue; Prosthesis, Knee, Patello/Femorotibial, Semi-Constrained, Uncemented, Porous, Coated, Polymer/Metal/Polymer; Prosthesis, Shoulder, Semi-Constrained, Metal/Polymer Cemented; Finger semi-constrained pyrolytic carbon uncemented prosthesis.
FDA’s recorded scope: Approval for a change to the raw material used in the processing of the subject device
FDA’s recorded scope: Approval to introduce new quarterly product endotoxin testing.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
MedtechLedger links 5 FDA enforcement entries through the recorded recalling firm or an exact submission number published in FDA’s recall data. 5 Class II records are represented. Each row is an enforcement entry; one recall event can cover several product entries. These counts describe this collection and do not measure a manufacturer’s safety record or an injury rate.
| Recall / product | Company | Classification | Report date | Source |
|---|---|---|---|---|
| Smith & Nephew, Inc. | Class II | Nov 11, 2026 | FDA | |
| Smith & Nephew, Inc. | Class II | Jun 24, 2026 | FDA | |
| Smith & Nephew, Inc. | Class II | Dec 24, 2025 | FDA | |
| Smith & Nephew, Inc. | Class II | May 28, 2025 | FDA | |
| Smith & Nephew, Inc. | Class II | Dec 11, 2024 | FDA |
Connections use the recorded recalling firm or the submission identifiers shown below. A shared submission connects the records; it does not establish that differently named legal applicants are interchangeable. Use the exact affected models, lots and instructions on each notice.
Source updated Nov 11, 2026. Retrieved Nov 21, 2026.
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.